Susanna Brauner

Publications
CV
Public outreach and news

Articles

Article: NEUROEPIDEMIOLOGY. 2024;:1-10
Long-Term Healthcare Resource Utilization and Costs among Patients with Myasthenia Gravis: A Swedish Nationwide Population-Based Study
Cai Q; Batista AE; Borsum J; Zhang Q; Isheden G; Kunovszki P; Gandhi K; Heerlein K; Brauner S
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2024;31(1):e16100
Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register-based cohort study
O'Connor L; Malmestrom C; Rodrigues RDS; Brauner S; Wikstrom A-K; Punga AR
Article: JAMA NEUROLOGY. 2022;79(11):1105-1112
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis The RINOMAX Randomized Clinical Trial
Piehl F; Eriksson-Dufva A; Budzianowska A; Feresiadou A; Hansson W; Hietala MA; Hakansson I; Johansson R; Jons D; Kmezic I; Lindberg C; Lindh J; Lundin F; Nygren I; Punga AR; Press R; Samuelsson K; Sundstrom P; Wickberg O; Brauner S; Frisell T
Article: NEUROLOGY. 2021;97(14):e1382-e1391
Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort Cross-sectional Analysis of the Swedish GEMG Study
Petersson M; Feresiadou A; Jons D; Ilinca A; Lundin F; Johansson R; Budzianowska A; Roos A-K; Kagstrom V; Gunnarsson M; Sundstrom P; Piehl F; Brauner S
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:667336
Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations
Creary LE; Gangavarapu S; Caillier SJ; Cavalcante P; Frangiamore R; Lie BA; Bengtsson M; Harbo HF; Brauner S; Hollenbach JA; Oksenberg JR; Bernasconi P; Maniaol AH; Hammarstrom L; Mantegazza R; Fernandez-Vina MA
Article: JAMA NEUROLOGY. 2020;77(8):974-981
Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis
Brauner S; Eriksson-Dufva A; Hietala MA; Frisell T; Press R; Piehl F
Article: JOURNAL OF CLINICAL INVESTIGATION. 2020;130(2):838-852
C-type lectin receptors Mcl and Mincle contro development of multiple sclerosis like neuroinflammation
N'diaye M; Brauner S; Flytzani S; Kular L; Warnecke A; Adzemovic MZ; Piket E; Min J-H; Edwards W; Mela F; Choi HY; Magg V; James T; Linden M; Reichardt HM; Daws MR; van Horssen J; Kockum I; Harris RA; Olsson T; Guerreiro-Cacais AO; Jagodic M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2018;194(3):315-326
The Sjogren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production
Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
Article: CARDIOVASCULAR RESEARCH. 2018;114(1):158-167
Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content
Brauner S; Jiang X; Thorlacius GE; Lundberg AM; Ostberg T; Yan Z-Q; Kuchroo VK; Hansson GK; Wahren-Herlenius M
Article: BIOLOGY OF SEX DIFFERENCES. 2017;8(1):34
Sex influences eQTL effects of SLE and Sjogren's syndrome-associated genetic polymorphisms
Linden M; Sepulveda JIR; James T; Thorlacius GE; Brauner S; Gomez-Cabrero D; Olsson T; Kockum I; Wahren-Herlenius M
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(10):1755-1763
H1N1 vaccination in Sjogren's syndrome triggers polyclonal B cell activation and promotes autoantibody production
Brauner S; Folkersen L; Kvarnstrom M; Meisgen S; Petersen S; Franzen-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmstrom V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):139
IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
Article: BIOLOGY OF SEX DIFFERENCES. 2017;8:16
Difference in clinical presentation between women and men in incident primary Sjogren's syndrome
Sepulveda JIR; Kvarnstrom M; Brauner S; Baldini C; Wahren-Herlenius M
Article: JOURNAL OF INTERNAL MEDICINE. 2015;278(3):323-332
Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease
Brauner S; Zhou W; Backlin C; Green TM; Folkersen L; Ivanchenko M; Lofstrom B; Xu-Monette ZY; Young KH; Pedersen LM; Moller MB; Sundstrom C; Enblad G; Baecklund E; Wahren-Herlenius M
Article: MULTIPLE SCLEROSIS JOURNAL. 2014;20(13):1727-1736
Interferon beta treatment of multiple sclerosis increases serum interleukin-7
Lundstrom W; Hermanrud C; Sjostrand M; Brauner S; Wahren-Herlenius M; Olsson T; Karrenbauer V; Hillert J; Fogdell-Hahn A
Article: JOURNAL OF IMMUNOLOGY. 2013;191(7):3753-3763
Expression of the Immune Regulator Tripartite-Motif 21 Is Controlled by IFN Regulatory Factors
Sjostrand M; Ambrosi A; Brauner S; Sullivan J; Malin S; Kuchroo VK; Espinosa A; Wahren-Herlenius M
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2009;206(8):1661-1671
Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway
Espinosa A; Dardalhon V; Brauner S; Ambrosi A; Higgs R; Quintana FJ; Sjostrand M; Eloranta M-L; Gabhann JN; Winqvist O; Sundelin B; Jefferies CA; Rozell B; Kuchroo VK; Wahren-Herlenius M
Article: LUPUS. 2007;16(1):10-17
Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun
Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Article: JOURNAL OF IMMUNOLOGY. 2006;176(10):6277-6285
The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death
Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
Article: MOLECULAR IMMUNOLOGY. 2006;43(6):588-598
Structural, functional and immunologic characterization of folded subdomains in the Ro52, protein targeted in Sjogren's syndrome
Ottosson L; Hennig J; Espinosa A; Brauner S; Wahren-Herlenius M; Sunnerhagen M

All other publications

Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(12):1840-1842
Clinical associations and expression pattern of the autoimmunity susceptibility factor DIORA-1 in patients with primary Sjogren's syndrome
Aqrawi LA; Mentlein L; Meneghel L; Bjork A; Thorlacius GE; Ivanchenko M; Sepulveda JIR; Skarstein K; Kvarnstrom M; Brauner S; Espinosa A; Wahren-Herlenius M
Letter: EXPERIMENTAL DERMATOLOGY. 2017;26(5):444-446
IL-22 binding protein regulates murine skin inflammation
Lindahl H; Martini E; Brauner S; Nikamo P; Serezal IG; Guerreiro-Cacais AO; Jagodic M; Eidsmo L; Stahle M; Olsson T
Thesis / dissertation: 2013
TRIM21/ Ro52 in B cell pathology
Brauner, Susanna
Letter: JOURNAL OF IMMUNOLOGY. 2009;183(12):7620-7621
Comment on "Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in Fibroblasts Response
Espinosa A; Brauner S; Ambrosi A; Kuchroo V; Wahren-Herlenius M

Employments

Senior Research Specialist, Department of Clinical Neuroscience, Karolinska Institutet, 2022-

Degrees and Education

Docent, Karolinska Institutet, 2023
Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2013
University Medical Degree, Karolinska Institutet, 2007

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI